AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 35555662 — intervention group
Group type: EXPERIMENTAL
Intervention: All conditions (CN, CAF, CN+CAF, PL)
Number of subjects: 12
Study 36252718 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexamethasone 24 mg IV (perioperatively)
Number of subjects: 290
Study 36252718 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 290
Study 36654288 — intervention group
Group type: EXPERIMENTAL
Intervention: Bumetanide 0.5 mg
Number of subjects: 120
Study 36654288 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 120
Study 34375695 — intervention group
Group type: EXPERIMENTAL
Intervention: Coronary stenting
Number of subjects: 0
Study 34375695 — intervention group
Group type: EXPERIMENTAL
Intervention: Bioabsorbable scaffolds
Number of subjects: 0
Study 34375695 — intervention group
Group type: COMPARATOR
Intervention: Stenting
Number of subjects: 0
Study 33840486 — intervention group
Group type: EXPERIMENTAL
Intervention: Haylage (grass-alfalfa mix)
Number of subjects: 7
Study 33840486 — intervention group
Group type: COMPARATOR
Intervention: Hay (alfalfa)
Number of subjects: 7
Study 33175600 — intervention group
Group type: EXPERIMENTAL
Intervention: 12vPHiD‐CV
Number of subjects: 61
Study 33175600 — intervention group
Group type: COMPARATOR
Intervention: PHiD‐CV
Number of subjects: 61
Study 34076869 — intervention group
Group type: EXPERIMENTAL
Intervention: Testicular sperm (Testi)
Number of subjects: 302
Study 34076869 — intervention group
Group type: COMPARATOR
Intervention: DGC
Number of subjects: 302
Study 34076869 — intervention group
Group type: EXPERIMENTAL
Intervention: PICSI
Number of subjects: 302
Study 34076869 — intervention group
Group type: EXPERIMENTAL
Intervention: MACS
Number of subjects: 302
Study 34076869 — intervention group
Group type: EXPERIMENTAL
Intervention: DGC and MACS
Number of subjects: 302
Study 33504410 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy for Insomnia (CBT-I)
Number of subjects: 24
Study 36451469 — intervention group
Group type: EXPERIMENTAL
Intervention: Nao‐Xin‐Tong capsule (NXT)
Number of subjects: 673
Study 36451469 — intervention group
Group type: EXPERIMENTAL
Intervention: Bu‐Yang‐Huan‐Wu (BYHW) granule
Number of subjects: 673
Study 36451469 — intervention group
Group type: EXPERIMENTAL
Intervention: Yang‐Yin‐Tong‐Nao granule (YYTN)
Number of subjects: 673
Study 36451469 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 673
Study 34500127 — intervention group
Group type: EXPERIMENTAL
Intervention: Stoss-dosed vitamin D
Number of subjects: 33
Study 36111808 — intervention group
Group type: EXPERIMENTAL
Intervention: Total Gut Restoration (TGR) system supplementation (five probiotic Bacillus strains, prebiotic mixture, immunoglobulin concentrate, amino acids and prebiotic flavonoids) for 5 days
Number of subjects: 0
Study 36111808 — intervention group
Group type: COMPARATOR
Intervention: Unsupplemented controls
Number of subjects: 0
Study 32023365 — intervention group
Group type: EXPERIMENTAL
Intervention: Active tDCS
Number of subjects: 0
Study 32023365 — intervention group
Group type: COMPARATOR
Intervention: Sham tDCS
Number of subjects: 0
Study 35366574 — intervention group
Group type: EXPERIMENTAL
Intervention: 4 mg AZ-009
Number of subjects: 24
Study 35366574 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study 33470648 — intervention group
Group type: COMPARATOR
Intervention: P-VIG (prolonged bout expending 300 kcal at 70% VO2R)
Number of subjects: 24
Study 33470648 — intervention group
Group type: EXPERIMENTAL
Intervention: P-MOD (prolonged bout expending 300 kcal at 50% VO2R)
Number of subjects: 24
Study 33470648 — intervention group
Group type: EXPERIMENTAL
Intervention: S-MOD (short bout expending 150 kcal at 50% VO2R)
Number of subjects: 24
Study 33470648 — intervention group
Group type: EXPERIMENTAL
Intervention: CTL (nonexercise control session)
Number of subjects: 24
Study 36261468 — intervention group
Group type: EXPERIMENTAL
Intervention: CCRT combined with aerobic exercise (CAE)
Number of subjects: 96
Study 36261468 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerobic exercise (AE)
Number of subjects: 96
Study 36261468 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 96
Study 34325888 — intervention group
Group type: EXPERIMENTAL
Intervention: Empagliflozin
Number of subjects: 0
Study 34325888 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 33027758 — intervention group
Group type: EXPERIMENTAL
Intervention: Dance group (n = 78)
Number of subjects: 134
Study 33027758 — intervention group
Group type: COMPARATOR
Intervention: Control group (n = 56)
Number of subjects: 134
Study 35130086 — intervention group
Group type: EXPERIMENTAL
Intervention: Epidural Morphine (5 mg) and Bupivacaine (0.25%, 2 mL)
Number of subjects: 100
Study 34539142 — intervention group
Group type: EXPERIMENTAL
Intervention: Pharmacist intervention with mutual cooperation system (Group C)
Number of subjects: 134
Study 34539142 — intervention group
Group type: COMPARATOR
Intervention: Pharmacist intervention without mutual cooperation system (Group B)
Number of subjects: 134
Study 34539142 — intervention group
Group type: COMPARATOR
Intervention: Pharmacist intervention without HFSR (Group A)
Number of subjects: 134
Study 32050099 — intervention group
Group type: EXPERIMENTAL
Intervention: Eccentric cycle training (ECC)
Number of subjects: 24
Study 32050099 — intervention group
Group type: COMPARATOR
Intervention: Conventional cycle training (CON)
Number of subjects: 24
Study 35438014 — intervention group
Group type: EXPERIMENTAL
Intervention: High-Intensity Interval Exercise (HIIE)
Number of subjects: 20
Study 35438014 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate-Intensity Continuous Exercise (MICE)
Number of subjects: 20
Study 35438014 — intervention group
Group type: COMPARATOR
Intervention: Control (CON)
Number of subjects: 20
Study 33975325 — intervention group
Group type: EXPERIMENTAL
Intervention: High protein (HP) diet (1.5 g protein/kg body weight)
Number of subjects: 54
Study 33975325 — intervention group
Group type: COMPARATOR
Intervention: Normal protein (NP) diet (0.8 g protein/kg body weight)
Number of subjects: 54
Study 35382702 — intervention group
Group type: EXPERIMENTAL
Intervention: Socially branded messages discouraging EC use (themes: general wellness, pride, health harms)
Number of subjects: 457
Study 35382702 — intervention group
Group type: EXPERIMENTAL
Intervention: Socially branded messages discouraging EC use (pride-themed messages)
Number of subjects: 457
Study 35382702 — intervention group
Group type: EXPERIMENTAL
Intervention: Socially branded messages discouraging EC use (general wellness and health harms themes)
Number of subjects: 457
Study 35382702 — intervention group
Group type: EXPERIMENTAL
Intervention: Socially branded messages discouraging EC use
Number of subjects: 457
Study 34593030 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified-Paleo diet with calorie counting
Number of subjects: 80
Study 34593030 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified-Paleo diet with fixed diet plan
Number of subjects: 80
Study 34593030 — intervention group
Group type: EXPERIMENTAL
Intervention: Medium-carbohydrate diet with calorie counting
Number of subjects: 80
Study 34593030 — intervention group
Group type: EXPERIMENTAL
Intervention: Medium-carbohydrate diet with fixed diet plan
Number of subjects: 80
Study 35382844 — intervention group
Group type: EXPERIMENTAL
Intervention: Dual long-acting bNAbs infusions (3BNC117-LS and 10-1074-LS) followed by Analytical Treatment Interruption (ATI)
Number of subjects: 72
Study 35382844 — intervention group
Group type: COMPARATOR
Intervention: Placebo infusions followed by ATI
Number of subjects: 72
Study 35382844 — intervention group
Group type: EXPERIMENTAL
Intervention: Open-label LS bNAbs after viral rebound in Stage 2
Number of subjects: 72
Study 35382844 — intervention group
Group type: EXPERIMENTAL
Intervention: Dual long-acting bNAbs infusions
Number of subjects: 72
Study 33717406 — intervention group
Group type: EXPERIMENTAL
Intervention: Vigabatrin therapy
Number of subjects: 0
Study 32097203 — intervention group
Group type: EXPERIMENTAL
Intervention: One suction device (Group 1)
Number of subjects: 30
Study 32097203 — intervention group
Group type: COMPARATOR
Intervention: Two suction devices (Group 2)
Number of subjects: 30
Study 32097203 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (post-wash)
Number of subjects: 30
Study 32097203 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (post-filtration)
Number of subjects: 30
Study 35196986 — intervention group
Group type: EXPERIMENTAL
Intervention: MynxGrip vascular closure device (VCD)
Number of subjects: 869
Study 35196986 — intervention group
Group type: COMPARATOR
Intervention: Manual compression (MC)
Number of subjects: 869
Study 35737383 — intervention group
Group type: EXPERIMENTAL
Intervention: FOLFOX (mFOLFOX6) with trastuzumab and nivolumab (1 mg/kg × 4/240 mg for up to 12 months)
Number of subjects: 88
Study 35737383 — intervention group
Group type: EXPERIMENTAL
Intervention: Ipilimumab (3 mg/kg × 4 for up to 12 weeks) with trastuzumab and nivolumab
Number of subjects: 88
Study 35737383 — intervention group
Group type: COMPARATOR
Intervention: FOLFOX (mFOLFOX6)
Number of subjects: 88
Study 35737383 — intervention group
Group type: COMPARATOR
Intervention: Ipilimumab
Number of subjects: 88
Study 32354380 — intervention group
Group type: EXPERIMENTAL
Intervention: Triglyceride-rich lipoprotein cholesterol (TRL-C)
Number of subjects: 976
Study 32354380 — intervention group
Group type: EXPERIMENTAL
Intervention: Small-dense low-density lipoprotein cholesterol (sdLDL-C)
Number of subjects: 976
Study 32354380 — intervention group
Group type: EXPERIMENTAL
Intervention: Both TRL-C and sdLDL-C
Number of subjects: 976
Study 33656394 — intervention group
Group type: EXPERIMENTAL
Intervention: Acute phenylalanine/tyrosine depletion (APTD)
Number of subjects: 0
Study 33656394 — intervention group
Group type: COMPARATOR
Intervention: Nutritionally balanced drink (Control)
Number of subjects: 0
Study 34338876 — intervention group
Group type: EXPERIMENTAL
Intervention: Novel electrosurgical temperature-controlled instrument
Number of subjects: 48
Study 34338876 — intervention group
Group type: COMPARATOR
Intervention: Cold-steel with localized bipolar cauterization (control)
Number of subjects: 48
Study 34338876 — intervention group
Group type: COMPARATOR
Intervention: Control side (cold-steel)
Number of subjects: 48
Study 33438360 — intervention group
Group type: EXPERIMENTAL
Intervention: Spironolactone
Number of subjects: 248
Study 33438360 — intervention group
Group type: COMPARATOR
Intervention: No intervention (Control group: non-DM patients)
Number of subjects: 248
Study 33438360 — intervention group
Group type: EXPERIMENTAL
Intervention: DM patients
Number of subjects: 248
Study 33516297 — intervention group
Group type: EXPERIMENTAL
Intervention: FnCas12a
Number of subjects: 3
Study 33516297 — intervention group
Group type: EXPERIMENTAL
Intervention: LbCas12a
Number of subjects: 3
Study 33516297 — intervention group
Group type: EXPERIMENTAL
Intervention: AsCas12a
Number of subjects: 3
Study 35129299 — intervention group
Group type: EXPERIMENTAL
Intervention: Group-based community health club effective use counselling
Number of subjects: 603
Study 35129299 — intervention group
Group type: EXPERIMENTAL
Intervention: Individualized effective use counselling
Number of subjects: 603
Study 35129299 — intervention group
Group type: EXPERIMENTAL
Intervention: Community-based PrEP dispensary
Number of subjects: 603
Study 35129299 — intervention group
Group type: COMPARATOR
Intervention: Standard-of-care PrEP delivery with individualized effective use counselling
Number of subjects: 603
Study 35129299 — intervention group
Group type: COMPARATOR
Intervention: Standard-of-care PrEP delivery with group-based community health effective use counselling
Number of subjects: 603
Study 34615624 — intervention group
Group type: EXPERIMENTAL
Intervention: Building blocks activity (LEGO robot creation)
Number of subjects: 0
Study 35125305 — intervention group
Group type: EXPERIMENTAL
Intervention: SVF-enriched autologous lipotransfer
Number of subjects: 15
Study 35125305 — intervention group
Group type: COMPARATOR
Intervention: Non-enriched autologous lipotransfer
Number of subjects: 15
Study 32507479 — intervention group
Group type: EXPERIMENTAL
Intervention: Mild therapeutic hypothermia (MTH; 32.0 °C-34.0 °C)
Number of subjects: 130
Study 32507479 — intervention group
Group type: COMPARATOR
Intervention: Fever control (35.5 °C-37.0 °C)
Number of subjects: 130
Study 32507479 — intervention group
Group type: EXPERIMENTAL
Intervention: Hb levels during early phase
Number of subjects: 130
Study 35533363 — intervention group
Group type: EXPERIMENTAL
Intervention: Internet-delivered cognitive behavioral therapy (ICBT)
Number of subjects: 187
Study 35533363 — intervention group
Group type: COMPARATOR
Intervention: Control group (waiting list)
Number of subjects: 187
Study 34462986 — intervention group
Group type: EXPERIMENTAL
Intervention: Deep Learning model based on T2WI
Number of subjects: 217
Study 34462986 — intervention group
Group type: EXPERIMENTAL
Intervention: Deep Learning model based on DWI
Number of subjects: 217
Study 34462986 — intervention group
Group type: EXPERIMENTAL
Intervention: Deep Learning model based on T2WI + DWI (combination)
Number of subjects: 217
Study 34462986 — intervention group
Group type: EXPERIMENTAL
Intervention: Radiomics model based on T2WI
Number of subjects: 217
Study 34462986 — intervention group
Group type: EXPERIMENTAL
Intervention: Radiomics model based on DWI
Number of subjects: 217
Study 34462986 — intervention group
Group type: EXPERIMENTAL
Intervention: Radiomics model based on T2WI + DWI (combination)
Number of subjects: 217
Study 34462986 — intervention group
Group type: EXPERIMENTAL
Intervention: Assessment by Radiologist 1
Number of subjects: 217
Study 34462986 — intervention group
Group type: EXPERIMENTAL
Intervention: Assessment by Radiologist 2
Number of subjects: 217
Study 33595427 — intervention group
Group type: EXPERIMENTAL
Intervention: 5% lidocaine cream applied perianally for 10 minutes (group 1)
Number of subjects: 252
Study 33595427 — intervention group
Group type: EXPERIMENTAL
Intervention: 1% lidocaine nerve block plus 5% lidocaine cream applied perianally for 10 minutes (group 2)
Number of subjects: 252
Study 33595427 — intervention group
Group type: EXPERIMENTAL
Intervention: 1% lidocaine nerve block plus 5% lidocaine cream applied perianally for 20 minutes (group 3)
Number of subjects: 252
Study 33595427 — intervention group
Group type: EXPERIMENTAL
Intervention: 1% lidocaine nerve block plus 5% lidocaine cream applied perianally and internally for 10 minutes (group 4)
Number of subjects: 252
Study 33595427 — intervention group
Group type: EXPERIMENTAL
Intervention: 1% lidocaine nerve block plus 5% lidocaine cream applied perianally and internally for 20 minutes (group 5)
Number of subjects: 252
Study 33595427 — intervention group
Group type: EXPERIMENTAL
Intervention: 1% lidocaine nerve block plus 5% lidocaine cream applied perianally and internally for 10 minutes (group 6)
Number of subjects: 252
Study 33595427 — intervention group
Group type: COMPARATOR
Intervention: PPNB only (control group 7)
Number of subjects: 252
Study 32216142 — intervention group
Group type: EXPERIMENTAL
Intervention: Concerns about family disruptions during deployment
Number of subjects: 223
Study 32216142 — intervention group
Group type: EXPERIMENTAL
Intervention: Harassment during deployment
Number of subjects: 223
Study 32216142 — intervention group
Group type: EXPERIMENTAL
Intervention: Postdeployment social support
Number of subjects: 223
Study 34952292 — intervention group
Group type: EXPERIMENTAL
Intervention: adrabetadex
Number of subjects: 56
Study 34952292 — intervention group
Group type: EXPERIMENTAL
Intervention: NPC-SS (Niemann-Pick Disease, type C1 Severity Scale)
Number of subjects: 56
Study 34782430 — intervention group
Group type: EXPERIMENTAL
Intervention: Dendritic cell vaccine targeting tumor blood vessel antigens with immediate dasatinib (Arm B)
Number of subjects: 16
Study 34782430 — intervention group
Group type: COMPARATOR
Intervention: Dendritic cell vaccine targeting tumor blood vessel antigens with delayed dasatinib (Arm A)
Number of subjects: 16
Study 34782430 — intervention group
Group type: EXPERIMENTAL
Intervention: Dendritic cell vaccine targeting tumor blood vessel antigens
Number of subjects: 16
Study 35347874 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive behavioural therapy (CBT) for MDD
Number of subjects: 8
Study 33655423 — intervention group
Group type: EXPERIMENTAL
Intervention: Dupilumab 200/300 mg every 2 weeks (q2w)
Number of subjects: 251
Study 33655423 — intervention group
Group type: EXPERIMENTAL
Intervention: Dupilumab 300 mg every 4 weeks (q4w)
Number of subjects: 251
Study 33655423 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 251
Study 33655423 — intervention group
Group type: EXPERIMENTAL
Intervention: Dupilumab 200/300 mg q2w and Dupilumab 300 mg q4w
Number of subjects: 251
Study 32445688 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive behavioural therapy (CBT) plus standardised medical care
Number of subjects: 368
Study 32445688 — intervention group
Group type: COMPARATOR
Intervention: Standardised medical care alone
Number of subjects: 368
Study 36204396 — intervention group
Group type: EXPERIMENTAL
Intervention: Fruits last meal
Number of subjects: 36
Study 36204396 — intervention group
Group type: EXPERIMENTAL
Intervention: Fruits first meal
Number of subjects: 36
Study 36204396 — intervention group
Group type: EXPERIMENTAL
Intervention: Postprandial exercise
Number of subjects: 36
Study 36204396 — intervention group
Group type: COMPARATOR
Intervention: Fruits last meal vs Fruits first meal
Number of subjects: 36
Study 35254390 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive SBP target <120 mm Hg
Number of subjects: 547
Study 35254390 — intervention group
Group type: COMPARATOR
Intervention: Standard SBP target <140 mm Hg
Number of subjects: 547
Study 35254390 — intervention group
Group type: COMPARATOR
Intervention: Intensive vs Standard Treatment
Number of subjects: 547
Study 35254390 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive Treatment in participants with history of cardiovascular disease
Number of subjects: 547
Study 36131389 — intervention group
Group type: EXPERIMENTAL
Intervention: VTC modality of NEUROPSI Breve
Number of subjects: 32
Study 36131389 — intervention group
Group type: COMPARATOR
Intervention: Face-to-face modality of NEUROPSI Breve
Number of subjects: 32
Study 36131389 — intervention group
Group type: EXPERIMENTAL
Intervention: Adapted version of NEUROPSI Breve
Number of subjects: 32
Study 36131389 — intervention group
Group type: EXPERIMENTAL
Intervention: Original version of NEUROPSI Breve
Number of subjects: 32
Study 36131389 — intervention group
Group type: EXPERIMENTAL
Intervention: Online (VTC) modality
Number of subjects: 32
Study 33162176 — intervention group
Group type: EXPERIMENTAL
Intervention: Facebook campaign
Number of subjects: 17271
Study 33162176 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 17271
Study 33162176 — intervention group
Group type: EXPERIMENTAL
Intervention: Facebook campaign in lowest SES quartile
Number of subjects: 17271
Study 33162176 — intervention group
Group type: COMPARATOR
Intervention: Control group in lowest SES quartile
Number of subjects: 17271
Study 33162176 — intervention group
Group type: EXPERIMENTAL
Intervention: Facebook campaign in second SES quartile
Number of subjects: 17271
Study 33162176 — intervention group
Group type: COMPARATOR
Intervention: Control group in second SES quartile
Number of subjects: 17271
Study 32179446 — intervention group
Group type: EXPERIMENTAL
Intervention: Primary debulking surgery (PDS) followed by 8x paclitaxel and carboplatin (TC regimen)
Number of subjects: 301
Study 32179446 — intervention group
Group type: COMPARATOR
Intervention: Neoadjuvant chemotherapy (NACT) with 4x TC, interval debulking surgery (IDS), 4x TC
Number of subjects: 301
Study 32179446 — intervention group
Group type: COMPARATOR
Intervention: Neoadjuvant chemotherapy (NACT)
Number of subjects: 301
Study 32179446 — intervention group
Group type: EXPERIMENTAL
Intervention: Primary debulking surgery (PDS)
Number of subjects: 301
Study 35877734 — intervention group
Group type: EXPERIMENTAL
Intervention: Spirulysat®
Number of subjects: 40
Study 33661306 — intervention group
Group type: EXPERIMENTAL
Intervention: PVE/HVE
Number of subjects: 199
Study 33661306 — intervention group
Group type: COMPARATOR
Intervention: PVE
Number of subjects: 199
Study 35875898 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture (ACU)
Number of subjects: 121
Study 35875898 — intervention group
Group type: EXPERIMENTAL
Intervention: Osteopathic medicine (OM)
Number of subjects: 121
Study 35875898 — intervention group
Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 121
Study 34002561 — intervention group
Group type: EXPERIMENTAL
Intervention: Fire needling
Number of subjects: 60
Study 34002561 — intervention group
Group type: COMPARATOR
Intervention: Filiform needling
Number of subjects: 60
Study 32378422 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 mg oral melatonin supplementation
Number of subjects: 20
Study 32378422 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study 36403564 — intervention group
Group type: EXPERIMENTAL
Intervention: DLR ss‐EPI
Number of subjects: 87
Study 36403564 — intervention group
Group type: COMPARATOR
Intervention: ss‐EPI
Number of subjects: 87
Study 33864989 — intervention group
Group type: EXPERIMENTAL
Intervention: MISSION‐CJ (wraparound treatment)
Number of subjects: 100
Study 33864989 — intervention group
Group type: EXPERIMENTAL
Intervention: High engagement in MISSION‐CJ
Number of subjects: 100
Study 32981534 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive remediation
Number of subjects: 60
Study 32981534 — intervention group
Group type: EXPERIMENTAL
Intervention: Long-acting injectable risperidone (LAI)
Number of subjects: 60
Study 32981534 — intervention group
Group type: COMPARATOR
Intervention: Oral risperidone
Number of subjects: 60
Study 32981534 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive remediation and LAI antipsychotic medication
Number of subjects: 60
Study 33879469 — intervention group
Group type: EXPERIMENTAL
Intervention: Deep learning approach using fundus photographs
Number of subjects: 1302
Study 33879469 — intervention group
Group type: EXPERIMENTAL
Intervention: Deep learning approach using fundus autofluorescence (FAF) images
Number of subjects: 1302
Study 32907565 — intervention group
Group type: EXPERIMENTAL
Intervention: Awareness of HIV positive status
Number of subjects: 1000
Study 32907565 — intervention group
Group type: EXPERIMENTAL
Intervention: On ART
Number of subjects: 1000
Study 32907565 — intervention group
Group type: EXPERIMENTAL
Intervention: Viral suppression
Number of subjects: 1000
Study 32907565 — intervention group
Group type: EXPERIMENTAL
Intervention: Awareness of HIV positive status by sex
Number of subjects: 1000
Study 32907565 — intervention group
Group type: EXPERIMENTAL
Intervention: On ART by sex
Number of subjects: 1000
Study 32907565 — intervention group
Group type: EXPERIMENTAL
Intervention: Viral suppression by sex
Number of subjects: 1000